Using innovative trial designs to accelerate drug oncology development

Accelerating clinical trials takes on special urgency in oncology. Patients and their families are seeking treatment for life-threatening diseases; drug developers understand that imperative acutely, whether they are large enterprises bringing therapies to market or smaller biotech companies pursuing validation for a new compound.

Toward that end, Parexel is advancing innovative approaches to optimize study design and streamline protocols.

One key aspect of these new clinical trial designs is that they permit changes after initiation, such as amending how patients are categorized and treated. These designs can cover all aspects of safety and efficacy with options for interim milestones to facilitate decision-making.

Return to Insights Center

Back

Access exclusive insights

Harness the power of clinical development with exclusive insights from our experts at Parexel

Would you like to hear from us in the future?

Stay connected with Parexel!

Accept

Decline